Difference between revisions of "Part:BBa K3142005"
Line 3: Line 3:
 
<partinfo>BBa_K3142005 short</partinfo>
 
<partinfo>BBa_K3142005 short</partinfo>
  
−
Angiotensin-converting enzyme in hypoallergenic infant milk formulas, which IC50 is 26.0 uM/L.The sequence has been optimized for lactic acid bacteria. It is a small molecule bioactive peptide that is difficult to directly biosynthesize. Therefore, the fusion expression strategy is currently used.
+
Angiotensin-converting enzyme in hypoallergenic infant milk formulas, which is a highly active hypotensive peptide.The sequence has been optimized for lactic acid bacteria. It is a small molecule bioactive peptide that is difficult to directly biosynthesize. Therefore, the fusion expression strategy is currently used.
  
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here

Revision as of 08:06, 21 October 2019


Antihypertensive dipeptide（VY）

Angiotensin-converting enzyme in hypoallergenic infant milk formulas, which is a highly active hypotensive peptide.The sequence has been optimized for lactic acid bacteria. It is a small molecule bioactive peptide that is difficult to directly biosynthesize. Therefore, the fusion expression strategy is currently used.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


References

  • Martin, M., A. Wellner, I. Ossowski, and T. Henle. 2008. Identification and quantification of inhibitors for Angiotensin-converting enzyme in hypoallergenic infant milk formulas.[J] Agric Food Chem 56:6333–6338.